FDA panel OKs what may soon be first gene therapy approved in US – WREX-TV
WREX-TV |
FDA panel OKs what may soon be first gene therapy approved in US
WREX-TV (HealthDay News) — A U.S. Food and Drug Administration advisory panel on Wednesday gave unanimous approval to what could soon be the first gene therapy to be marketed in the United States. The treatment, called CTL019, genetically tweaks a patient’s … |
|
Novel Gene Therapy for Leukemia Clears FDA Panel
Scientific American A panel of outside experts convened by the FDA voted 10-0 Wednesday to recommend the approval of Novartis’ CAR-T therapy, called CTL019, for the treatment of children and young adults with advanced leukemia. The vote marks a pivotal milestone for this … |
PMLiVE |
Novartis’ CAR–T clears FDA panel with relative ease
PMLiVE In CAR-T therapy patients’ cells are harvested and modified so they are more likely to seek out and destroy cancer cells expressing a particular antigen, in this case CD19. Once reprogrammed the T cells are infused back into the patient in order to … |
|
Immunotherapy Drugs Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025
Medgadget (blog) Immunotherapy is the management of a disease by enhancing, suppressing, or inducing an immune response. Some immunotherapies are designed to magnify or elicit an immune response. They are known as activation immunotherapies. However, some … |